Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Accumulated Expenses (2018 - 2019)

DiaMedica Therapeutics' Accumulated Expenses history spans 2 years, with the latest figure at $299000.0 for Q3 2019.

  • For Q3 2019, Accumulated Expenses changed N/A year-over-year to $299000.0; the TTM value through Sep 2019 reached $299000.0, changed N/A, while the annual FY2018 figure was $808000.0, N/A changed from the prior year.
  • Accumulated Expenses reached $299000.0 in Q3 2019 per DMAC's latest filing, up from $224000.0 in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $808000.0 in Q4 2018 to a low of $224000.0 in Q2 2019.